FDAnews Device Daily Bulletin

MEDTRONIC SHARES UP ON STENT DATA

Sept. 7, 2005
A A

Medtronic Inc. shares rose nearly 2 percent on Tuesday on growing evidence the company's newly launched Endeavor drug-coated stent will be a viable competitor in Europe, analysts said. Longer-term study data presented at a weekend cardiology meeting in Sweden confirmed the product's favorable safety record, a key selling point for the device, a tiny wire-mesh tube that disperses a drug to keep cleared arteries open, analysts said.

Yahoo News (http://biz.yahoo.com/rb/050906/medtronic_stock.html?.v=1)